Advertisement

Reactions Weekly

, Volume 1766, Issue 1, pp 129–129 | Cite as

Durvalumab

Hyperprogression of non-metastatic lung cancer: case report
Case report
  • 11 Downloads

Reference

  1. Khreis TJ, et al. Durvalumab-induced hyperprogressive disease in nonmetastatic lung cancer. Journal of Oncology Practice 15: 217-219, No. 4, Apr 2019. Available from: URL: https://ascopubs.org/doi/pdf/10.1200/JOP.18.00739 - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations